SE0900647L - Prognostiskt förfarande - Google Patents

Prognostiskt förfarande

Info

Publication number
SE0900647L
SE0900647L SE0900647A SE0900647A SE0900647L SE 0900647 L SE0900647 L SE 0900647L SE 0900647 A SE0900647 A SE 0900647A SE 0900647 A SE0900647 A SE 0900647A SE 0900647 L SE0900647 L SE 0900647L
Authority
SE
Sweden
Prior art keywords
subject
mrp2
human
determining
acid derivative
Prior art date
Application number
SE0900647A
Other languages
English (en)
Other versions
SE536288C2 (sv
Inventor
Hans-Juergen Gruss
Ronaldoude Elferink
Dirk De Waart
Bruno Stieger
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of SE0900647L publication Critical patent/SE0900647L/sv
Publication of SE536288C2 publication Critical patent/SE536288C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6447—Fluorescence; Phosphorescence by visual observation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173845—Amine and quaternary ammonium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/18—Sulfur containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/203332—Hydroxyl containing
SE0900647A 2008-05-15 2009-05-13 Prognostiskt förfarande SE536288C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0808777.7A GB0808777D0 (en) 2008-05-15 2008-05-15 Prognostic method

Publications (2)

Publication Number Publication Date
SE0900647L true SE0900647L (sv) 2009-11-16
SE536288C2 SE536288C2 (sv) 2013-08-06

Family

ID=39571356

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0900647A SE536288C2 (sv) 2008-05-15 2009-05-13 Prognostiskt förfarande

Country Status (15)

Country Link
US (2) US8318504B2 (sv)
AT (1) AT506910A1 (sv)
AU (1) AU2009201920B2 (sv)
BE (1) BE1018734A3 (sv)
CA (1) CA2666009A1 (sv)
DE (1) DE102009021315A1 (sv)
DK (1) DK200900613A (sv)
ES (1) ES2360727B1 (sv)
FR (1) FR2931239A1 (sv)
GB (2) GB0808777D0 (sv)
IT (1) IT1394172B1 (sv)
LU (1) LU91569B1 (sv)
NL (1) NL2002886C2 (sv)
NZ (1) NZ576949A (sv)
SE (1) SE536288C2 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2773653A4 (en) * 2011-11-02 2015-08-05 Broad Inst Inc FLUORESCENT SUBSTRATES FOR DETERMINING THE ACTIVITY OF A LYSIN-MODIFYING ENZYME
CN104090056A (zh) * 2014-06-27 2014-10-08 上海雷允上药业有限公司 Hplc-elsd法对贝羚胶囊中猪去氧胆酸的含量测定方法
US9745613B2 (en) 2014-07-22 2017-08-29 The Broad Institute, Inc. Compounds, substrates and methods related to histone deacetylases
JP2018199648A (ja) * 2017-05-29 2018-12-20 五稜化薬株式会社 新規トランスポーター機能解析用蛍光物質

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264514A (en) * 1977-11-14 1981-04-28 Abbott Laboratories Method and reagents for measuring the level of conjugated bile acids
IL84356A (en) 1986-11-05 1991-08-16 Sumitomo Electric Industries Liver function testing apparatus
US4848349A (en) * 1987-04-29 1989-07-18 Sherman Igor A Substance and method for measuring hepatic blood flow
JPH0657216B2 (ja) * 1988-09-14 1994-08-03 住友電気工業株式会社 肝機能検査装置
GB9517043D0 (en) 1995-08-19 1995-10-25 Univ Birmingham The use of bile acid derivatives
US5928625A (en) 1997-03-13 1999-07-27 Mallinckrodt Inc. Method of measuring physiological function
GB9716962D0 (en) 1997-08-12 1997-10-15 Univ Birmingham Liver function test
WO2000001297A1 (de) 1998-07-01 2000-01-13 Andreas Hoeft Bestimmung der leberfunktion anhand einer plasmaverschwinderate
US7601494B2 (en) * 1999-03-17 2009-10-13 The University Of North Carolina At Chapel Hill Method of screening candidate compounds for susceptibility to biliary excretion
US6339714B1 (en) 1999-09-13 2002-01-15 Bo Chen Apparatus and method for measuring concentrations of a dye in a living organism
DE10143995A1 (de) 2001-09-07 2003-04-03 Pulsion Medical Sys Ag System und Computerprogramm zur Bestimmung von Kreislaufgrößen eines Patienten

Also Published As

Publication number Publication date
GB2459976B (en) 2012-11-28
ITVR20090067A1 (it) 2009-11-16
NL2002886A1 (nl) 2009-11-17
US20130042671A1 (en) 2013-02-21
NL2002886C2 (en) 2010-06-08
US20090286277A1 (en) 2009-11-19
ES2360727A1 (es) 2011-06-08
IT1394172B1 (it) 2012-05-25
AT506910A1 (de) 2009-12-15
SE536288C2 (sv) 2013-08-06
GB0908270D0 (en) 2009-06-24
AU2009201920A1 (en) 2009-12-03
AU2009201920B2 (en) 2013-08-29
US8318504B2 (en) 2012-11-27
LU91569B1 (en) 2010-07-30
GB0808777D0 (en) 2008-06-18
IE20090373A1 (en) 2010-03-03
NZ576949A (en) 2011-06-30
GB2459976A (en) 2009-11-18
CA2666009A1 (en) 2009-11-15
BE1018734A3 (fr) 2011-07-05
DK200900613A (en) 2009-11-16
DE102009021315A1 (de) 2009-11-19
ES2360727B1 (es) 2012-04-27
US8513023B2 (en) 2013-08-20
FR2931239A1 (fr) 2009-11-20

Similar Documents

Publication Publication Date Title
BR112018069849A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático
WO2009092613A3 (de) Verfahren zum modellieren eines individuellen zahnersatzes
NZ592473A (en) Urinary biomarkers for predicting long-term dialysis
EP1888089A4 (en) EX-VIVO GENE EXPRESSION IN FULL BLOOD AS A MODEL FOR THE ASSESSMENT OF INDIVIDUAL VARIATION AGAINST FOOD ADDITIVES
WO2010031056A3 (en) Methods and compositions for modulating ire1, src, and abl activity
EA201270020A1 (ru) Определение риска развития атеросклеротической болезни сердца
WO2010091049A3 (en) Diagnosis and treatment of cancer
ATE548967T1 (de) Verfahren und gerät zur vorhersage von elektrochemischer dissoziation
WO2007140185A3 (en) Methods for non-invasive analyte measurement
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
BRPI0709271B8 (pt) métodos para a detecção de uma doença renal
WO2014179765A3 (en) Novel human mirnas for use in diagnosis, prognosis and therapy of human conditions and diseases
EA201690465A1 (ru) Способ оценки эффектов композиции, содержащей микроорганизмы, на кишечную микробиоту
WO2011156734A3 (en) Method of characterizing vascular diseases
MX366369B (es) Metodo para un ensayo de deteccion de farmacos basado en celulas y el uso del mismo.
WO2012120546A3 (en) Method for monitoring anticoagulant therapy
SE0900647L (sv) Prognostiskt förfarande
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
WO2013009146A3 (ko) 당뇨망막병증 진단용 마커 및 이의 용도
WO2010097553A3 (fr) Procédé de diagnostic d'une vascularite
BR112012028010A2 (pt) anticorpo isolado, célula, ácido nucleíco isolado, método de identificação de um primeiro anticorpo que se liga a um epítopo antigênico tat425 ligado or um anticorpo, métodos de inibir o crescimento de uma célula, de tratamento terapêutico de determinação da presença de uma proteína de tat425 e de diagnóstico da presença de um tumor em um mamífero
ATE528651T1 (de) Diagnoseverfahren für pulmonale arterielle hypertonie
WO2008147206A3 (en) Means and methods for classifying samples of multiple sclerosis patients

Legal Events

Date Code Title Description
NUG Patent has lapsed